Medicare to Continue to Cover Avastin Regardless of What FDA Decides

Medicare will continue to cover Avastin for breast cancer treatment even if U.S. Food and Drug Administration Commissioner Peggy Hamburg decides to withdraw Avastin for such use, according to Don McLeod, a spokesman for the Centers for Medicare and Medicaid. "The FDA decision, when it comes, does not affect CMS," McLeod told Reuters. An FDA advisory committee recommended unanimously that Avastin no longer be used to treat breast cancer, saying that the risks of the drug far outweighed any...Full Story
Commenting on this article is closed.